FORT COLLINS - Marizyme Inc. (OTC: MRZM) - a company focused on acquiring, developing and commercializing late-stage drug assets for acute care use - has appointed new members to its board. Marizyme adds new board members BizWest - Dec 18, 2018
FORT COLLINS - Marizyme Inc. (OTC: MRZM) - a company focused on acquiring, developing and commercializing late-stage drug assets for acute care use - has appointed new members to its board.